Navigation Links
Clarithromycin tablets to be launched in India soon

Ranbaxy Laboratories Limited has recently launched its approved generic formulation of clarithromycin// immediate release tablets in the US, according to a press release. Ranbaxy has been given the green signal to manufacture and market Clarithromycin tablets—250 mg and 500 mg under the Ranbaxy label. Clarithromycin tablets are indicated for the treatment of mild to moderate infections caused by susceptible strains of designated micro-organisms.

The US Food and Drug Administration (FDA), has determined that Ranbaxy’s formulation can be expected to have the same therapeutic effect as an equivalent dose of Abbott’s Biaxin Filmtab (clarithromycin tablets, USP). Jim Meehan, vice-president of Sales and Marketing for Ranbaxy Pharmaceuticals Inc (RPI) on behalf of the whole team of Ranbaxy has been stated as saying that he is very delighted to market the drug and also mentioned that they have plans to bring the product to the Indian market very soon
'"/>




Page: 1

Related medicine news :

1. Ranbaxy Launches Clarithromycin, Terbinafine Tablets in Japan
2. Cadila gets US FDA approval for Promethazine tablets
3. Say no to detox tablets
4. Manic Ecstasy: Man gets Into a Frenzy after a Record Consumption of 40,000 ecstasy tablets
5. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
6. Asmanex Twisthaler launched by Schering-Plough for treatment of asthma
7. New initiative launched to fight malaria by repelling mosquitoes
8. Guide for physicians launched to help them identify alcohol disorders
9. New X-ray machine launched by GE Healthcare
10. Historic trial for tuberculosis launched together by leading drug companies
11. New tetanus-diphtheria combination vaccine launched by Serum Institute of India
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... Dallas, Texas (PRWEB) , ... June 24, 2016 ... ... 12th International Conference and Scientific Sessions in Dallas that it will receive two ... Announcement of the grants came as PHA marked its 25th anniversary by recognizing ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners ... extensive sequencing and genomics experience, as Vice President of North American Capital Sales at ... responsible for leading the sales team in the commercialization of the HTG EdgeSeq system ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
(Date:6/23/2016)... Ill. and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment ... Astellas Farma Brasil as the company,s second affiliate in Latin America . ... ... General Manager of Astellas Farma Colombia ... ...
Breaking Medicine Technology: